Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2

N. Zhou(Tianjin Medical University General Hospital), Yi Zhang(Beijing Research Institute of Mechanical and Electrical Technology)

Research Square

August 17, 2020

10.21203/rs.3.rs-57440/v1

Cited by 0

Related Papers

Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells

|Stem Cell Research & Therapy|2021|86

Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation

|Human Cell|2023|15

Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2

|Cell Death Discovery|2021|11